Evidence map›Paper›PMID 24518835›Full record

ArticleEuropean journal of human genetics : EJHG2014

Homozygous microdeletion of exon 5 in ZNF277 in a girl with specific language impairment.

Fabiola Ceroni, Nuala H Simpson, Clyde Francks, Gillian Baird, Gina Conti-Ramsden, Ann Clark, Patrick F Bolton, Elizabeth R Hennessy, Peter Donnelly, David R Bentley and 10 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Fabiola CeroniDipartimento di Farmacia e Biotecnologie, University of Bologna, Bologna, Italy.
Nuala H SimpsonWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Clyde Francks1] Max Planck Institute for Psycholinguistics, Nijmegen, Netherlands [2] Donders Institute for Brain, Cognition & Behaviour, Nijmegen, Netherlands.
Gillian BairdGuy's & St Thomas NHS Foundation Trust, Newcomen Children's Neurosciences Centre, St Thomas' Hospital, London, UK.
Gina Conti-RamsdenSchool of Psychological Sciences, The University of Manchester, Manchester, UK.
Ann ClarkSpeech and Hearing Sciences, Queen Margaret University, Edinburgh, UK.
Patrick F BoltonDepartments of Child & Adolescent Psychiatry & Social Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Kings College London, London, UK.
Elizabeth R HennessyUniversity Child Health and DMDE, University of Aberdeen, Aberdeen, UK.
Peter DonnellyWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
David R BentleyIllumina Cambridge Ltd., Chesterford Research Park, Little Chesterford, Essex, UK.
Hilary MartinWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
IMGSAC
SLI Consortium
WGS500 Consortium
Jeremy ParrInstitute of Neuroscience and Health and Society, Newcastle University, Newcastle, UK.
Alistair T Pagnamenta1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK [2] NIHR Biomedical Research Centre, Oxford and Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Elena MaestriniDipartimento di Farmacia e Biotecnologie, University of Bologna, Bologna, Italy.
Elena BacchelliDipartimento di Farmacia e Biotecnologie, University of Bologna, Bologna, Italy.
Simon E Fisher1] Max Planck Institute for Psycholinguistics, Nijmegen, Netherlands [2] Donders Institute for Brain, Cognition & Behaviour, Nijmegen, Netherlands.
Dianne F NewburyWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Centre for Human Genetics · GBQueen Margaret University · GBSt Thomas' Hospital · GBUniversity of Bologna · ITKing's College London · GBRadboud University Nijmegen · NL

Funding

Medical Research Council G1000569Medical Research Council G1000569/1Medical Research Council MR/J003719/1Wellcome Trust 060774Wellcome Trust 076566Wellcome Trust 090532Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Specific language impairment (SLI), an unexpected failure to develop appropriate language skills despite adequate non-verbal intelligence, is a heterogeneous multifactorial disorder with a complex genetic basis. We identified a homozygous microdeletion of 21,379 bp in the ZNF277 gene (NM_021994.2), encompassing exon 5, in an individual with severe receptive and expressive language impairment. The microdeletion was not found in the proband's affected sister or her brother who had mild language impairment. However, it was inherited from both parents, each of whom carries a heterozygous microdeletion and has a history of language problems. The microdeletion falls within the AUTS1 locus, a region linked to autistic spectrum disorders (ASDs). Moreover, ZNF277 is adjacent to the DOCK4 and IMMP2L genes, which have been implicated in ASD. We screened for the presence of ZNF277 microdeletions in cohorts of children with SLI or ASD and panels of control subjects. ZNF277 microdeletions were at an increased allelic frequency in SLI probands (1.1%) compared with both ASD family members (0.3%) and independent controls (0.4%). We performed quantitative RT-PCR analyses of the expression of IMMP2L, DOCK4 and ZNF277 in individuals carrying either an IMMP2L_DOCK4 microdeletion or a ZNF277 microdeletion. Although ZNF277 microdeletions reduce the expression of ZNF277, they do not alter the levels of DOCK4 or IMMP2L transcripts. Conversely, IMMP2L_DOCK4 microdeletions do not affect the expression levels of ZNF277. We postulate that ZNF277 microdeletions may contribute to the risk of language impairments in a manner that is independent of the autism risk loci previously described in this region.

Indexed as

ExonsSequence DeletionCase-Control StudiesChild Development Disorders, PervasiveChild, PreschoolCohort StudiesDNA-Binding ProteinsDNA Copy Number VariationsEndopeptidasesFemaleGene FrequencyGenetic LociGTPase-Activating ProteinsHomozygoteHumansLanguage Development DisordersDNA-Binding ProteinsDOCK4 protein, humanEndopeptidasesGTPase-Activating ProteinsIMMP2L protein, humanRNA, Messengerzinc finger protein 277, human

Identifiers

PMID24518835
PMCPMC4169542
OpenAlexW2058171585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.